http://en.people.cn/n3/2025/0124/c90000-20270304.html
In order to produce high-quality astaxanthin, Zhang Yong, the founder of Yunnan Alfa Company, found an excellent place suitable for the growth of Haematococcus pluvialis between Kunming and Dali, Chuxiong. Chuxiong, with an average annual temperature of 14.8-21.9℃, an average sunshine of 2450 hours, and no industrial pollution, is known as the Emerald of Central Yunnan. In addition to the natural environment, scientific research strength is also worth considering.
Yunnan Alfa Biotechnology Co., Ltd. was established in 2007. It is a high-tech enterprise and provincial key leading agricultural enterprise engaged in the cultivation, processing and sales of Haematococcus pluvialis cell engineering. It is a rare enterprise in the world that masters two technologies to produce Haematococcus pluvialis. It has created a new model of industrialized production of Haematococcus pluvialis using barren mountain resources in China and built a world-leading Haematococcus pluvialis breeding base. In order to improve the company’s product structure and enhance its risk resistance, in March 2013, the company established a wholly-owned subsidiary, Yunnan Alcon Biotechnology Co., Ltd., in the Bio-Industrial Park of Chuxiong Economic Development Zone, specializing in the research and development of astaxanthin terminal products.
Since its establishment in 2007, Alfa has successively carried out technical cooperation with scientific research institutes such as the Institute of Oceanology, Chinese Academy of Sciences and Shanghai Ocean University, forming a joint research team composed of academicians, professors, doctors and enterprise technical backbones; it has successively established four innovative platforms: Yunnan Province Haematococcus Pluvialis Engineering Research Center, Yunnan Enterprise Technology Center, Academician Hou Baorong Workstation, Haematococcus Germplasm Cultivation and Astaxanthin Product Development National and Local Joint Engineering Research Center. As a result, the company has extended from raw material manufacturing to high value-added terminal product manufacturing, forming a complete industrial chain.
Alfa takes cell engineering technology as its starting point and focuses on the development of high-value-added astaxanthin products. At present, Alfa has a 400,000 square meter Haematococcus pluvialis culture base.